|
February 13, 2012
|
| 09:09 EDT |  | AGN |
|
|
February 8, 2012
|
| 08:47 EDT | | AGN |
|
| 06:21 EDT |  | AGN |
|
|
February 6, 2012
|
| 10:05 EDT |  | AGN |
|
|
February 3, 2012
|
| 08:31 EDT | | AGN |
| theflyonthewall.com: | Allergan shares should be bought following decline, says RBC Capital | | After Allergan provided lower than expected 2012 EPS guidance and the stock fell 2.8%, RBC Capital thinks the sell-off is overdone, as the firm notes that the guidance was expected to be conservative while part of the guidance shortfall was due to predicted currency effects not fully baked into estimates. The firm maintains an Outperform rating. :theflyonthewall.com |
|
| 06:19 EDT | | AGN |
| theflyonthewall.com: | Allergan stops selling Lap-Band to 1-800-GET-THIN clinics, LA Times reports | | Allergan (AGN) has decided to cease sales of its surgically implanted Lap-Band weight loss device to the Southern California company 1-800-GET-THIN, which has been hit by at least five patient deaths in the last years, according to the Los Angeles Times. Reference Link :theflyonthewall.com |
|
|
February 2, 2012
|
| 21:55 EDT |  | AGN |
| theflyonthewall.com: | Jim Cramer's "Mad Money" | | Jim Cramer said that now's the time to 'tip-toe' back into the markets, not run for the exits. Cramer said it's true that the markets have been up six weeks in a row, but that doesn't mean that investors need to worry about bubbles. Cramer said he hears the calls of a bubble in tech stocks, but with bellwethers like Intel (INTC) and Microsoft (MSFT) trading at just 10X earnings, a fraction of what they were just a few years ago, how can that be a bubble? He said that even Apple (AAPL) trades at just 7X earnings after backing out the company's nearly $100B in cash. Some have called a bubble in retail, but Walmart (WMT) still trades below where it did a decade ago. The same is true with the oil stocks, with companies like Exxon-Mobil (XOM) and Chevron (CVX) both trading at super-low valuations. Cramer recalled how he received hate mail after endorsing the Google (GOOG) IPO at $80 a share, only to see that company double and double and double again. Cramer explained that with 840M active users of Facebook, there's no denying that retail demand for this IPO will be huge. However with so few shares available, just about all of those investors will be forced to buy in the aftermarket. He said if shares double on the IPO, it's likely that the valuation would be too high and investors should sell no matter what. If shares rise only slightly however, it's possible that shares of Facebook would be worth holding onto. EXECUTIVE DECISION: Cramer once again welcomed with Jack Hartung, CFO of Chipotle Mexican Grill (CMG), a stock that dipped 2% after it reported a 2c earnings miss on a 23% rise in revenues. Shares of Chipotle are up 650% since Cramer first got behind the company six years ago. Cramer told viewers that the dip in Chipotle's stock price is the perfect buying opportunity and they should stick with the company. Cramer also sat down with Irvin Simon, chairman, president and CEO of Hain Celestial (HAIN), which delivered a 3c earnings beat on a 33% gain in revenues form last year. Shares of Hain have returned 129% since Cramer first recommended it in April 2010. Cramer remained bullish on Hain. Then, Cramer spoke with David Pyott, chairman, president and CEO of Allergan (AGN), a stock that got hammered down 3% after the company reported only in-line sales and earnings. Pyott was bullish on his company's flagship product, Botox, and on the outlook for some of their drugs in the pipeline -- including ones for overactive bladder. Cramer remained bullish on Allergan and said Thursday's price dip makes for an excellent entry point for investors. LIGHTNING ROUND: (Bullish) HUN; CBOU; SBUX. (Bearish) ARMH; BTU; MWW. Reference Link :theflyonthewall.com |
|
| 12:37 EDT | | AGN |
|
| 11:44 EDT | | AGN |
|
| 11:34 EDT | | AGN |
| theflyonthewall.com: | Allergan: European has "lots of opportunity" and "done astoundingly well" | | :theflyonthewall.com |
|
| 11:32 EDT | | AGN |
|
| 11:30 EDT |  | AGN |
| theflyonthewall.com: | Allergan sees FY12 cash flow in excess of $1B | | :theflyonthewall.com |
|
| 11:29 EDT | | AGN |
|
| 11:25 EDT | | AGN |
|
| 11:23 EDT | | AGN |
| theflyonthewall.com: | Allergan will not pursue expansion of LAP-BAND to adolescents | | The company will conduct a study for LAP-BAND at the suggestion of the FDA :theflyonthewall.com |
|
| 11:19 EDT | | AGN |
| theflyonthewall.com: | Allergan: Possible that surgeons are moving to higher price competitive products |
 Subscribe for More Information :theflyonthewall.com |
|
| 11:15 EDT | | AGN |
|
| 11:13 EDT | | AGN |
| theflyonthewall.com: | Allergan: Botox sales in Europe impacted by price reductions, austerity measures |
Subscribe for More Information :theflyonthewall.com |
|
| 11:06 EDT | | AGN |
| theflyonthewall.com: | Allergan plans to "execute off large number of regulatory approvals" | | :theflyonthewall.com |
|
| 11:06 EDT | | AGN |
|
| 09:06 EDT | | AGN |
|
| 09:05 EDT | | AGN |
| theflyonthewall.com: | Allergan sees FY12 EPS $4.13-$4.19 vs. consensus $4.21 | | Sees FY12 revenue $5.65B-$5.85B vs. consensus $5.89B. :theflyonthewall.com |
|
| 09:04 EDT | | AGN |
|
|
February 1, 2012
|
| 14:53 EDT | | AGN |
| theflyonthewall.com: | Companies reporting Before the Market Open on Thursday, February 2 | | Notable companies reporting before the opening bell include Allergan (AGN), Boston Scientific (BSX), Cameron International (CAM), Cardinal Health (CAH), Cigna (CI), CME (CME), Dow Chemical (DOW), Goodrich (GR), International Paper (IP), Kellogg (K), Mastercard (MA), Merck (MRK), Roper Industries (ROP), Ryder System (R), Sara Lee (SLE), Spectra Energy (SE), Starwood Hotels (HOT), and TECO Energy (TE). :theflyonthewall.com |
|
| 13:17 EDT | | AGN |
|
| 09:57 EDT | | AGN |
|
|
January 31, 2012
|
| 11:21 EDT | | AGN |
|
